Skip Navigation



Human Molecular Genetics Advance Access published online on October 7, 2004

Human Molecular Genetics, doi:10.1093/hmg/ddh309
© 2004 by Oxford University Press
This Article
Right arrow Advance Access manuscript (PDF) Freely available
Right arrow All Versions of this Article:
13/22/2781    most recent
ddh309v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Cariboni, A.
Right arrow Articles by Maggi, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cariboni, A.
Right arrow Articles by Maggi, R.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?


Article

The product of X-linked Kallmann's syndrome gene (KAL1) affects the migratory activity of Gonadotropin-Releasing Hormone (GnRH)-producing neurons

Anna Cariboni 1, Federica Pimpinelli 1, Sophia Colamarino 2, Roberta Zaninetti 1, Margherita Piccolella 1, Cristiano Rumio 3, Flavio Piva 1, Elena I. Rugarli 4, and Roberto Maggi 5*

1 Laboratory of Developmental Neuroendocrinology, Department of Endocrinology, Centre of Excellence on Neurodegenerative Diseases, University of Milano, Milano, Italy
2 Telethon Institute for Genetic and Medicine (TIGEM), Naples, Italy; Laboratory of Genetics, The Salk Institute, La Jolla, CA, USA
3 Department of Human Morphology, University of Milano, Milano, Italy
4 Telethon Institute for Genetic and Medicine (TIGEM), Naples, Italy
5 Laboratory of Developmental Neuroendocrinology, Department of Endocrinology, Centre of Excellence on Neurodegenerative Diseases, University of Milano, Via G. Balzaretti, 9, 20133 Milano, Italy

* To whom correspondence should be addressed. E-mail: roberto.magi{at}unimi.it.


   Abstract

X-linked Kallmann's syndrome (KS) is a genetic disease characterised by anosmia and hypogonadism due to impairment in the development of olfactory axons and in the migration of Gonadotropin-Releasing Hormone (GnRH)-producing neurons. Deletions or point mutations of a gene located at Xp22.3 (KAL1) are responsible for the disease. This gene encodes for a secreted heparin binding-protein (KAL or anosmin-1) which exhibits similarities with cell-adhesion molecules. In the present study, we show for the first time a direct action of anosmin-1 on the migratory activity of GnRH neurons. Specifically, we exposed immortalised migrating GnRH neurons (GN11 cells) to conditioned media (CM) of COS or CHO cells transiently transfected with human KAL1 gene in microchemotaxis and collagen gel assays. We found that KAL-enriched media produced a cell-specific chemotactic response of GN11 cells. None of the CM enriched on three forms of anosmin-1 carrying different missense mutations (N267K, E514K, F517L) found in patients affected by X-linked KS, affected the chemomigration of GN11 cells. Anosmin binds to the GN11 cell surface by interacting with the heparan-sulphate proteoglycans and the chemotactic effect of anosmin-1-enriched CM can be specifically blocked by heparin or by heparinase pre-treatment. These results strongly suggest an involvement of anosmin-1 in the control of the migratory behavior of GnRH neurons and provide novel information on the pathogenesis of KS.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Endocr. Rev.Home page
L. M. Cotton, M. K. O'Bryan, and B. T. Hinton
Cellular Signaling by Fibroblast Growth Factors (FGFs) and Their Receptors (FGFRs) in Male Reproduction
Endocr. Rev., April 1, 2008; 29(2): 193 - 216.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
X. Zhu, A. S. Gleiberman, and M. G. Rosenfeld
Molecular Physiology of Pituitary Development: Signaling and Transcriptional Networks
Physiol Rev, July 1, 2007; 87(3): 933 - 963.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. M. Nielsen-Preiss, M. P. Allen, M. Xu, D. A. Linseman, J. E. Pawlowski, R. J. Bouchard, B. C. Varnum, K. A. Heidenreich, and M. E. Wierman
Adhesion-Related Kinase Induction of Migration Requires Phosphatidylinositol-3-Kinase and Ras Stimulation of Rac Activity in Immortalized Gonadotropin-Releasing Hormone Neuronal Cells
Endocrinology, June 1, 2007; 148(6): 2806 - 2814.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
P. Magni, E. Dozio, M. Ruscica, H. Watanobe, A. Cariboni, R. Zaninetti, M. Motta, and R. Maggi
Leukemia Inhibitory Factor Induces the Chemomigration of Immortalized Gonadotropin-Releasing Hormone Neurons through the Independent Activation of the Janus Kinase/Signal Transducer and Activator of Transcription 3, Mitogen-Activated Protein Kinase/Extracellularly Regulated Kinase 1/2, and Phosphatidylinositol 3-Kinase/Akt Signaling Pathways
Mol. Endocrinol., May 1, 2007; 21(5): 1163 - 1174.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
B. Bhagavath, N. Xu, M. Ozata, R. L. Rosenfield, D. P. Bick, R. J. Sherins, and L. C. Layman
KAL1 mutations are not a common cause of idiopathic hypogonadotrophic hypogonadism in humans
Mol. Hum. Reprod., March 1, 2007; 13(3): 165 - 170*.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
A. Cariboni, J. Hickok, S. Rakic, W. Andrews, R. Maggi, S. Tischkau, and J. G. Parnavelas
Neuropilins and Their Ligands Are Important in the Migration of Gonadotropin-Releasing Hormone Neurons
J. Neurosci., February 28, 2007; 27(9): 2387 - 2395.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
F. Cerrato, J. Shagoury, M. Kralickova, A. Dwyer, J. Falardeau, M. Ozata, G. Van Vliet, P. Bouloux, J. E Hall, F. J Hayes, et al.
Coding sequence analysis of GNRHR and GPR54 in patients with congenital and adult-onset forms of hypogonadotropic hypogonadism
Eur. J. Endocrinol., November 1, 2006; 155(suppl_1): S3 - S10.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
E. B. Trarbach, E. M. F. Costa, B. Versiani, M. de Castro, M. T. M. Baptista, H. M. Garmes, B. B. de Mendonca, and A. C. Latronico
Novel Fibroblast Growth Factor Receptor 1 Mutations in Patients with Congenital Hypogonadotropic Hypogonadism with and without Anosmia
J. Clin. Endocrinol. Metab., October 1, 2006; 91(10): 4006 - 4012.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Okubo, F. Sakai, E. L. Lau, G. Yoshizaki, Y. Takeuchi, K. Naruse, K. Aida, and Y. Nagahama
Forebrain Gonadotropin-Releasing Hormone Neuronal Development: Insights from Transgenic Medaka and the Relevance to X-Linked Kallmann Syndrome
Endocrinology, March 1, 2006; 147(3): 1076 - 1084.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. A. Tobet and G. A. Schwarting
Minireview: Recent Progress in Gonadotropin-Releasing Hormone Neuronal Migration
Endocrinology, March 1, 2006; 147(3): 1159 - 1165.
[Abstract] [Full Text] [PDF]


Home page
DevelopmentHome page
A. Cariboni, S. Rakic, A. Liapi, R. Maggi, A. Goffinet, and J. G. Parnavelas
Reelin provides an inhibitory signal in the migration of gonadotropin-releasing hormone neurons
Development, November 1, 2005; 132(21): 4709 - 4718.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
H. Kim, S R Herrick, E Lemyre, S Kishikawa, J A Salisz, S Seminara, M E MacDonald, G A P Bruns, C C Morton, B J Quade, et al.
Hypogonadotropic hypogonadism and cleft lip and palate caused by a balanced translocation producing haploinsufficiency for FGFR1
J. Med. Genet., August 1, 2005; 42(8): 666 - 672.
[Full Text] [PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.